In the Democratic Republic of the Congo, a Public Health Emergency of International Concern was declared due to an Ebola outbreak caused by the Bundibugyo virus. A WHO Technical Advisory Group was convened to address the situation. The group recommended that the Ervebo vaccine be evaluated in a clinical trial for Bundibugyo virus disease.

Further details on the outbreak and the advisory group's recommendations are available from ReliefWeb, including information on the vaccine trial and the context of the ongoing outbreak.